Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Income Tax Expense history
Currency unavailable · from the income statement
No Income Tax Expense data reported for this period type.
Income Tax Expense vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $89.84M USD | +889.7% | +153.5% | 41.3% | |
NMRANeumora Therapeutics, Inc. Common Stock | LTM Mar 2026 | $55K USD | -80.6% | — | — |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $1K USD | — | +0.0% | — |
| LTM Mar 2026 | $0 USD | — | — | — | |
RAPPRapport Therapeutics, Inc. Common Stock | LTM Mar 2026 | $0 USD | — | — | 0.0% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | LTM Mar 2026 | $0 USD | — | — | — |
| LTM Mar 2026 | $0 USD | — | — | — | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +404.6% | +76.7% | 20.6% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.